Pantoprazolo Doc (Pantoprazole Sodium Sesquihydrate)

Pantoprazole, the active ingredient in Pantoprazolo Doc, is a proton pump inhibitor presented as an oral dosage form for systemic use. It reduces gastric acid secretion and is employed in the management of acid‑related gastrointestinal disorders such as gastro‑oesophageal reflux disease, erosive oesophagitis, NSAID‑induced ulcers and Zollinger‑Ellison syndrome.

GNH USA supplies Pantoprazolo Doc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazolo Doc belongs to the proton pump inhibitor class and is used to treat conditions caused by excess gastric acid.

- Gastro‑oesophageal reflux disease (GERD): reduces acid exposure and promotes healing of the oesophageal lining. - Erosive oesophagitis: facilitates ulcer healing and symptom relief. - NSAID‑induced gastric ulcer: protects the gastric mucosa by lowering acid production. - Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid associated with gastrin‑producing tumours.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: loose stools, usually transient. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: severe diarrhoea with abdominal pain. - Hypomagnesemia: low magnesium levels, may cause muscle cramps or arrhythmia. - Elevated liver enzymes: signs of hepatic stress, monitored via blood tests.

Before initiating therapy, consider the following safety measures.

- Assess renal function: adjust use in patients with severe impairment. - Monitor magnesium levels: especially during prolonged treatment. - Separate dosing from antacids: avoid reduced absorption. - Use cautiously in hepatic impairment: monitor liver enzymes. - Store at room temperature: keep in the original container, protect from moisture.

Pantoprazolo Doc may interact with several medicines; awareness of interaction severity is essential.

Major Interactions (Avoid): - Ketoconazole: reduced absorption of ketoconazole. - Atazanavir: decreased exposure, risking therapeutic failure. - Clopidogrel: diminished activation, potentially lowering antiplatelet effect. - Warfarin: possible increase in INR, requiring close monitoring.

Moderate Interactions (Monitor Closely): - Methotrexate: increased serum levels, risk of toxicity. - Digoxin: elevated concentrations, may cause cardiac effects. - Iron supplements: decreased iron absorption, consider timing separation.